We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

The wrong prescription

4 April 2004

The pill would insure Aventis shareholders against the main risk in Sanofi s hostile bid. That’s an interesting concept. But the pill would allow the board to turn down an improved offer from Sanofi. Shareholders have no reason to give it this freedom.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)